These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 22977326

  • 1. Histologic characteristics of hepatocellular carcinomas showing atypical enhancement patterns on 4-phase MDCT examination.
    Kim I, Kim MJ.
    Korean J Radiol; 2012; 13(5):586-93. PubMed ID: 22977326
    [Abstract] [Full Text] [Related]

  • 2. Histological characteristics of small hepatocellular carcinomas showing atypical enhancement patterns on gadoxetic acid-enhanced MR imaging.
    Choi YS, Rhee H, Choi JY, Chung YE, Park YN, Kim KW, Kim MJ.
    J Magn Reson Imaging; 2013 Jun; 37(6):1384-91. PubMed ID: 23172629
    [Abstract] [Full Text] [Related]

  • 3. Multiphasic MDCT enhancement pattern of hepatocellular carcinoma smaller than 3 cm in diameter: tumor size and cellular differentiation.
    Yoon SH, Lee JM, So YH, Hong SH, Kim SJ, Han JK, Choi BI.
    AJR Am J Roentgenol; 2009 Dec; 193(6):W482-9. PubMed ID: 19933622
    [Abstract] [Full Text] [Related]

  • 4. Enhancement patterns of hepatocellular carcinomas on multiphasicmultidetector row CT: comparison with pathological differentiation.
    Lee JH, Lee JM, Kim SJ, Baek JH, Yun SH, Kim KW, Han JK, Choi BI.
    Br J Radiol; 2012 Sep; 85(1017):e573-83. PubMed ID: 22919011
    [Abstract] [Full Text] [Related]

  • 5. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS, Kim SH, Kang TW, Song KD, Choi D, Park CK.
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [Abstract] [Full Text] [Related]

  • 6. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT.
    Park VY, Choi JY, Chung YE, Kim H, Park MS, Lim JS, Kim KW, Kim MJ.
    Liver Int; 2014 Nov; 34(10):1593-602. PubMed ID: 24673802
    [Abstract] [Full Text] [Related]

  • 7. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
    Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, Gabata T.
    AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
    [Abstract] [Full Text] [Related]

  • 8. SPIO-enhanced MRI findings of well-differentiated hepatocellular carcinomas: correlation with MDCT findings.
    Kim SH, Lee WJ, Lim HK, Park CK.
    Korean J Radiol; 2009 Aug; 10(2):112-20. PubMed ID: 19270856
    [Abstract] [Full Text] [Related]

  • 9. Small hepatocellular carcinomas in cirrhosis: differences in contrast enhancement effects between helical CT and MR imaging during multiphasic dynamic imaging.
    Hayashida M, Ito K, Fujita T, Shimizu A, Sasaki K, Tanabe M, Matsunaga N.
    Magn Reson Imaging; 2008 Jan; 26(1):65-71. PubMed ID: 17566685
    [Abstract] [Full Text] [Related]

  • 10. Arterial enhancement of hepatocellular carcinoma before radiofrequency ablation as a predictor of postablation local tumor progression.
    Park Y, Kim YS, Rhim H, Lim HK, Choi D, Lee WJ.
    AJR Am J Roentgenol; 2009 Sep; 193(3):757-63. PubMed ID: 19696290
    [Abstract] [Full Text] [Related]

  • 11. Arterioportal shunt: prevalence in small hemangiomas versus that in hepatocellular carcinomas 3 cm or smaller at two-phase helical CT.
    Byun JH, Kim TK, Lee CW, Lee JK, Kim AY, Kim PN, Ha HK, Lee MG.
    Radiology; 2004 Aug; 232(2):354-60. PubMed ID: 15215556
    [Abstract] [Full Text] [Related]

  • 12. Prediction of poorly differentiated hepatocellular carcinoma using contrast computed tomography.
    Nakachi K, Tamai H, Mori Y, Shingaki N, Moribata K, Deguchi H, Ueda K, Inoue I, Maekita T, Iguchi M, Kato J, Ichinose M.
    Cancer Imaging; 2014 Apr 22; 14(1):7. PubMed ID: 25608454
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Enhancement patterns of hepatocellular carcinoma at contrast-enhanced US: comparison with histologic differentiation.
    Jang HJ, Kim TK, Burns PN, Wilson SR.
    Radiology; 2007 Sep 22; 244(3):898-906. PubMed ID: 17709836
    [Abstract] [Full Text] [Related]

  • 15. Assessment of Gd-EOB-DTPA-enhanced MRI for HCC and dysplastic nodules and comparison of detection sensitivity versus MDCT.
    Inoue T, Kudo M, Komuta M, Hayaishi S, Ueda T, Takita M, Kitai S, Hatanaka K, Yada N, Hagiwara S, Chung H, Sakurai T, Ueshima K, Sakamoto M, Maenishi O, Hyodo T, Okada M, Kumano S, Murakami T.
    J Gastroenterol; 2012 Sep 22; 47(9):1036-47. PubMed ID: 22526270
    [Abstract] [Full Text] [Related]

  • 16. Gadoxetic acid-enhanced MRI findings of early hepatocellular carcinoma as defined by new histologic criteria.
    Rhee H, Kim MJ, Park YN, Choi JS, Kim KS.
    J Magn Reson Imaging; 2012 Feb 22; 35(2):393-8. PubMed ID: 21990116
    [Abstract] [Full Text] [Related]

  • 17. Triple-phase MDCT of hepatocellular carcinoma.
    Lee KH, O'Malley ME, Haider MA, Hanbidge A.
    AJR Am J Roentgenol; 2004 Mar 22; 182(3):643-9. PubMed ID: 14975963
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic accuracy of contrast-enhanced dynamic CT for small hypervascular hepatocellular carcinoma and assessment of dynamic enhancement patterns: Results of two-year follow-up using cone-beam CT hepatic arteriography.
    Choi YR, Chung JW, Yu MH, Lee M, Kim JH.
    PLoS One; 2018 Mar 22; 13(9):e0203940. PubMed ID: 30231076
    [Abstract] [Full Text] [Related]

  • 19. Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.
    Ishigami K, Yoshimitsu K, Nishihara Y, Irie H, Asayama Y, Tajima T, Nishie A, Hirakawa M, Ushijima Y, Okamoto D, Taketomi A, Honda H.
    Radiology; 2009 Feb 22; 250(2):435-43. PubMed ID: 19095782
    [Abstract] [Full Text] [Related]

  • 20. Characterization of small (≤3 cm) hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article.
    Shin SK, Kim YS, Choi SJ, Shim YS, Jung DH, Kwon OS, Choi DJ, Kim JH.
    Medicine (Baltimore); 2017 Jul 22; 96(29):e7278. PubMed ID: 28723741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.